Predictors of chronotropic incompetence in the pacemaker patient population

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Christoph MelzerHeinz Theres

Abstract

We prospectively evaluated results from cardiopulmonary exercise testing for chronotropic incompetence (CI) in a cohort of 292 pacemaker patients. In addition, we evaluated comorbidity and antiarrhythmic patient data as indicators of CI. On the basis of exercise stress testing and application of the definition of CI by Wilkoff, 51% of our cohort was categorized as having CI. Indications for pacemaker implant for this patient group were 42% atrioventricular block, 56% sinus node disease, and 59% atrial fibrillation. Maximum oxygen uptake (VO(2) max) and exercise duration were significantly reduced among CI pacemaker patients, whereas oxygen uptake at the anaerobic threshold remained unchanged. The following clinical characteristics were significant predictors of CI: existence of coronary artery disease (P = 0.038), presence of an acquired valvular heart disease (P = 0.037), and former cardiac surgery (P = 0.041). Age, gender, arterial hypertension, cardiomyopathy, congenital heart disease, left ventricular ejection fraction, and time period between stress-exercise examination and pacemaker implantation were not significant predictors of CI. Chronic antiarrhythmic therapy with digitalis (P = 0.013), beta blockers (P = 0.036), and...Continue Reading

References

Feb 1, 1979·Clinical Cardiology·C F ChinM H Ellestad
Feb 1, 1990·Pacing and Clinical Electrophysiology : PACE·R CorbelliB L Wilkoff
Jun 1, 1990·Pacing and Clinical Electrophysiology : PACE·J M FeuerM H Ellestad
Oct 1, 1990·Pacing and Clinical Electrophysiology : PACE·C P LauW H Leung
Jan 1, 1990·Clinical Cardiology·M Rosenqvist
Jul 1, 1987·Pacing and Clinical Electrophysiology : PACE·F A JohnstonT Fyfe
Nov 1, 1988·Pacing and Clinical Electrophysiology : PACE·G RognoniP Rossi
Jun 1, 1989·Pacing and Clinical Electrophysiology : PACE·A KallrydL Rydén
Jul 1, 1972·Circulation·J J RubensteinR W DeSanctis
Jul 1, 1984·The American Journal of Cardiology·R D WiensH L Kennedy
Oct 1, 1995·Pacing and Clinical Electrophysiology : PACE·G N KayS M Dailey
Feb 18, 1999·JAMA : the Journal of the American Medical Association·M S LauerT H Marwick
Nov 4, 2000·Pacing and Clinical Electrophysiology : PACE·M MeineH J Trappe
Jun 2, 2001·The New England Journal of Medicine·M PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival Study Group
May 28, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Katsuya TakemuraKunio Miyatake
Jan 14, 2004·Chest·Philip J GentleskJ Edwin Atwood

❮ Previous
Next ❯

Citations

Feb 16, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Christoph Melzer, Henryk Dreger
Feb 7, 2014·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Mauro BiffiTibor Malacky
Oct 28, 2008·Pacing and Clinical Electrophysiology : PACE·James ComanUNKNOWN LIFE Study Results
Jul 8, 2010·Journal of Emergencies, Trauma, and Shock·Hans-Joachim Trappe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Pacing and Clinical Electrophysiology : PACE
Justin D ShaberSoo G Kim
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Herbert NägeleMaria Angeles Castel
© 2022 Meta ULC. All rights reserved